Free Trial
NASDAQ:DMAAU

Drugs Made in America Acquisition (DMAAU) Stock Price, News & Analysis

Drugs Made in America Acquisition logo
$10.30 +0.05 (+0.49%)
As of 05/27/2025 01:11 PM Eastern

About Drugs Made in America Acquisition Stock (NASDAQ:DMAAU)

Key Stats

Today's Range
$10.26
$10.30
50-Day Range
$10.12
$10.30
52-Week Range
$10.00
$10.82
Volume
471 shs
Average Volume
57,817 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the pharmaceutical industry. Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 and our telephone number is (954) 870-3099.

Receive DMAAU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drugs Made in America Acquisition and its competitors with MarketBeat's FREE daily newsletter.

DMAAU Stock News Headlines

DMAA Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp
Trump’s Bitcoin Reserve is No Accident…
For the first time in history, we have a president who understands crypto's potential to bypass the banking system entirely. And Wall Street's biggest players know it. I've created a blueprint revealing how everyday investors can turn this historic shift into potentially life-changing wealth. Like the 75,000 new millionaires created in the last bull run— only this time with institutional backing.
Drugs Made In America Acquisition Corp. Units (DMAAU)
See More Headlines

DMAAU Stock Analysis - Frequently Asked Questions

Drugs Made in America Acquisition's stock was trading at $10.00 on January 1st, 2025. Since then, DMAAU shares have increased by 3.0% and is now trading at $10.30.
View the best growth stocks for 2025 here
.

Drugs Made in America Acquisition (DMAAU) raised $200 million in an initial public offering on Tuesday, January 28th 2025. The company issued 20,000,000 shares at $10.00 per share. Clear Street served as the underwriter for the IPO.

Drugs Made in America Acquisition's lock-up period expires on Monday, July 28th. Drugs Made in America Acquisition had issued 20,000,000 shares in its initial public offering on January 28th. The total size of the offering was $200,000,000 based on an initial share price of $10.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Shares of DMAAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Investment Offices
Sub-Industry
Trading
Current Symbol
NASDAQ:DMAAU
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:DMAAU) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners